Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Gastrointestinal Cancer
Erschienen in: Journal of Gastrointestinal Cancer 2/2017

12.07.2016 | Original Research

Interfering Effect of Black Tea Consumption on Diagnosis of Pancreatic Cancer by CA 19-9

verfasst von: Ali Abdul Hussein S. AL-Janabi, Ekhlas F. Tawfeeq

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The study aims to determine the possible effects of black tea consumption on the level of CA 19-9 antigen in the human body.

Methods

The level of CA 19-9 was measured in 270 healthy individuals who consumed heavy amounts of black tea.

Results

About 43.3 % of involved individuals were revealed to have elevated levels of CA 19-9. Males with high values of CA 19-9 represented the greatest number of involved individuals. The cutoff value of high levels of CA 19-9 in all individuals was ranged 69–105 U/ml.

Conclusions

Consuming heavy amounts of black tea could be considered an important interfering factor that affects the levels of CA 19-9. The cutoff or predictive value of CA 19-9 in heavy-consuming people of black tea was determined.
Literatur
1.
Kannagi R. Carbohydrate antigen sialyl Lewis a-its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J. 2007;30:189–209.PubMed
2.
Giannasca PJ, Giannasca KT, Leichtner AM, Neutra MR. Human intestinal M cells display the sialyl Lewis a antigen. Infectious and Immunity. 1999;67(2):946–53.
3.
Sakamoto J, Furukawa K, Cordon-Cardo C, Yin BW, Rettig WJ, Oettgen HF, et al. Expression of Lewis a, Lewis b, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res. 1986;46:1553–61.PubMed
4.
5.
McLaughlin R, OʼHanlon D, Kerin M, Kenny P, Grimes H, Given HF. Are elevated levels of the tumour marker CA 19-9 of any clinical significance?—an evaluation. Ir J Med Sc. 1999;168(2):124–6.CrossRef
6.
Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointestinal Oncology. 2012;3(2):105–19.
7.
An X, Li Y, Lin X, Wang F, Feng F, Xu R, et al. Prognostic value of serum CA 19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy. Chinese J Cancer. 2009;28(3):240–4.
8.
Humphris JL, Chang DK, Johns AL, Scarlett CJ, Pajic M, Jones MD, et al. The prognostic and predictive value of serum CA 19-9 in pancreatic cancer. Annals Oncology. 2012, January;1–10.
9.
Passserini R, Cassatella MC, Boveri S, Salvatici M, Radice D, Zorzino L, et al. Routine testing and comparison of two automated immunoassays in a reference oncology center. Am J Clin Pathol. 2012;138:281–7.CrossRef
10.
Ferrone CR, Finkelstein DM, Thayer SP, Muzikansky A, Castillo CF, Warshaw AL. Peroperative CA 19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J clinical Oncology. 2006;24(18):2897–902.CrossRef
11.
Marcouizos G, Ignatiadou E, Papanikolaou GE, Ziogas D, Fatouros M. Highly elevated serum levels of CA 19-9 in choledocholithiasis: a case report. Cases J. 2009;2:6662.CrossRefPubMedPubMedCentral
12.
La Greca G, Sofia M, Lombardo R, Latteri S, Ricotta A, Puleo S, et al. Adjusting CA 19-9 values to predict malignancy in obstructive jaundice: influence of bilirubin and c-reactive protein. World J Gastroenterol. 2012;18(31):4150–5.CrossRefPubMedPubMedCentral
13.
Howaizi M, Abboura M, Krespine C, Sbai-Idrissi M, Marty O, Djabbari-Sobhani M. A new cause for CA 19-9 elevation: heavy tea consumption. Gut. 2003;52:912–6.CrossRef
14.
Vestergaard EM, Hein HO, Meyer H, Grunnet N, Jørgensen J, Wolf H, et al. Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. Clin Chem. 1999;45(1):54–61.PubMed
15.
Ramdani D, Chaudhry A, Seal C. Chemical composition, plant secondary metabolites, and minerals of green and black teas and the effect of different tea-to-water ratios during their extraction on the composition of their spent leaves as potential additives for ruminants. J Agric Food Chem. 2013;61:4961–7.CrossRefPubMed
16.
Anesini C, Ferraro GE, Filip R. Total polyphenol content and antioxidant capacity of commercially available tea (Camellia sinensis) in Argentina. J Agric Food Chem. 2008;56:9225–9.CrossRefPubMed
17.
Bayer D, Jansen J, Beltz LA. Differential effects of tea extracts on growth and cytokine production by normal and leukemic human leukocytes. Functional Foods in Health and Disease. 2012;2(4):72–85.
18.
Verma RJ, Trivedi MH, Chinoy NJ. Amelioration by black tea extract of sodium fluoride induced hemolysis of human red blood cell corpuscles. Research Report Fluoride. 2006;39(4):261–5.
19.
Bhatt PR, Pandya KB, Sheth NR. Camellia sinensis (L): the medicinal beverage: a review. International J Pharmaceutical Scientific Review and Research. 2010;3(2):6–9.
20.
Simon M, Horovská L, Greksák M, Dušinský R, Nakano M. Antihemolytic effect of rooibos tea (Aspalathus linearis) on red blood cells of Japanese quails. Gen Physiol Biophys. 2000;19:365–71.PubMed
21.
Grinberg LN, Newmark H, Kitrossky N, Rahamim E, Chevion M, Rachmilewitz EA. Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharmacol. 1997;54(9):973–8.CrossRefPubMed
22.
Sengupta A, Ghosh S, Das S. Tea can protect against aberrant crypt foci formation during azoxymethane induced rat colon carcinogenesis. J Exp Clin Cancer Res. 2003;22(2):185–91.PubMed
23.
Murugan RS, Mohan KV, Uchida K, Hara Y, Prathiba D, Hagini S. Modulatory effects of black yea polyphenols on oxidant-antioxidant profile and expression of proliferation, apoptosis, and angiogenesis-associated proteins in the rat forestomach carcinogenesis model. J Gastroenterol. 2007;42:352–61.CrossRefPubMed
24.
Oz HS, Ebersole JL. Green tea polyphenols mediated apoptosis in intestinal epithelial cells by a fadd-dependent pathway. J Cancer Therapy. 2010;1:105–13.CrossRef
Metadaten
Titel
Interfering Effect of Black Tea Consumption on Diagnosis of Pancreatic Cancer by CA 19-9
verfasst von
Ali Abdul Hussein S. AL-Janabi
Ekhlas F. Tawfeeq
Publikationsdatum
12.07.2016
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 2/2017
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-016-9855-z

Weitere Artikel der Ausgabe 2/2017

Journal of Gastrointestinal Cancer 2/2017 Zur Ausgabe

Original Research

Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab

Letter to the Editor

Which Is Important: Incision Length or Oncological Outcome?

Review Article

The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the Bed

Original Research

Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study

Case Report

Extramedullary Involvement of the Sigmoid Colon with Acute Lymphocytic Leukemia

Review Article

Minimally Invasive Surgical Approaches for Pancreatic Adenocarcinoma: Recent Trends

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise